How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/calcipotriene-plus-betamethasone-dipropionate-ointment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Calcipotriene plus betamethasone dipropionate ointment — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Calcipotriene plus betamethasone dipropionate ointment (Calcipotriene plus betamethasone dipropionate ointment) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical corticosteroid and vitamin D analog. Area: Dermatology.

phase 2 Topical corticosteroid and vitamin D analog Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Calcipotriene plus betamethasone dipropionate ointment (Calcipotriene plus betamethasone dipropionate ointment) — LEO Pharma. Calcipotriene plus betamethasone dipropionate ointment works by reducing inflammation and slowing the growth of skin cells in the treatment of psoriasis.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Calcipotriene plus betamethasone dipropionate ointment TARGET	Calcipotriene plus betamethasone dipropionate ointment	LEO Pharma	phase 2	Topical corticosteroid and vitamin D analog
IDP-124 Lotion	IDP-124 Lotion	Bausch Health Americas, Inc.	phase 3	Topical corticosteroid and vitamin D analog combination	Vitamin D receptor (VDR) and glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical corticosteroid and vitamin D analog class)

LEO Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Calcipotriene plus betamethasone dipropionate ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/calcipotriene-plus-betamethasone-dipropionate-ointment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab